Public conversations about the physician shortage often drift toward blame, timelines, and policy decisions, which can distract from the reality that nothing important was done incorrectly. The following clarifications are … Read more
Stability You Can Trust Private equity brings the comforting assurance that nothing in healthcare will remain recognizable for long, which is exactly the kind of dynamism patients and clinicians secretly … Read more
A Historic Announcement, Numerically Speaking WASHINGTON—Standing before a patriotic arrangement of flags, laminated charts, and a pie graph labeled “Winning,” President Donald Trump announced Monday that prescription drug prices are … Read more
The 340B program thrives by avoiding questions other programs insist on asking, quietly prioritizing institutional flexibility over patient-level proof while regulators celebrate efficiency without the inconvenience of answers.
It has been a hard week for pharmacy benefit managers. Not financially. Emotionally. Several PBMs were asked to explain things they normally keep in their footnotes. Some of them were … Read more
WASHINGTON—In a reassuring display of regulatory consistency, federal officials reaffirmed this week that physicians should not be allowed to own hospitals due to “obvious conflicts of interest,” while insurance conglomerates … Read more